Philip Hasel
University of Edinburgh
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Philip Hasel.
Nature Communications | 2015
Paul Baxter; Karen Bell; Philip Hasel; Angela M. Kaindl; Michael Fricker; Derek Thomson; Sean P. Cregan; Thomas H. Gillingwater; Giles E. Hardingham
How the brain’s antioxidant defenses adapt to changing demand is incompletely understood. Here we show that synaptic activity is coupled, via the NMDA receptor (NMDAR), to control of the glutathione antioxidant system. This tunes antioxidant capacity to reflect the elevated needs of an active neuron, guards against future increased demand and maintains redox balance in the brain. This control is mediated via a programme of gene expression changes that boosts the synthesis, recycling and utilization of glutathione, facilitating ROS detoxification and preventing Puma-dependent neuronal apoptosis. Of particular importance to the developing brain is the direct NMDAR-dependent transcriptional control of glutathione biosynthesis, disruption of which can lead to degeneration. Notably, these activity-dependent cell-autonomous mechanisms were found to cooperate with non-cell-autonomous Nrf2-driven support from astrocytes to maintain neuronal GSH levels in the face of oxidative insults. Thus, developmental NMDAR hypofunction and glutathione system deficits, separately implicated in several neurodevelopmental disorders, are mechanistically linked.
Nature Communications | 2015
Karen Bell; Bashayer Al-Mubarak; Marc-André Martel; Sean McKay; Nicola Wheelan; Philip Hasel; Nóra M. Márkus; Paul Baxter; Ruth F. Deighton; Andrea Serio; Bilada Bilican; Sudhir Chowdhry; Paul J. Meakin; Michael L.J. Ashford; David J. A. Wyllie; Robert H. Scannevin; Siddharthan Chandran; John D. Hayes; Giles E. Hardingham
Forebrain neurons have weak intrinsic antioxidant defences compared with astrocytes, but the molecular basis and purpose of this is poorly understood. We show that early in mouse cortical neuronal development in vitro and in vivo, expression of the master-regulator of antioxidant genes, transcription factor NF-E2-related-factor-2 (Nrf2), is repressed by epigenetic inactivation of its promoter. Consequently, in contrast to astrocytes or young neurons, maturing neurons possess negligible Nrf2-dependent antioxidant defences, and exhibit no transcriptional responses to Nrf2 activators, or to ablation of Nrf2s inhibitor Keap1. Neuronal Nrf2 inactivation seems to be required for proper development: in maturing neurons, ectopic Nrf2 expression inhibits neurite outgrowth and aborization, and electrophysiological maturation, including synaptogenesis. These defects arise because Nrf2 activity buffers neuronal redox status, inhibiting maturation processes dependent on redox-sensitive JNK and Wnt pathways. Thus, developmental epigenetic Nrf2 repression weakens neuronal antioxidant defences but is necessary to create an environment that supports neuronal development.
Nature Communications | 2017
Philip Hasel; Owen Dando; Zoeb Jiwaji; Paul Baxter; Alison C. Todd; Samuel Heron; Nóra M. Márkus; Jamie McQueen; David W. Hampton; Megan Torvell; Sachin S. Tiwari; Sean McKay; Abel Eraso-Pichot; Antonio Zorzano; Roser Masgrau; Elena Galea; Siddharthan Chandran; David J. A. Wyllie; T. Ian Simpson; Giles E. Hardingham
The influence that neurons exert on astrocytic function is poorly understood. To investigate this, we first developed a system combining cortical neurons and astrocytes from closely related species, followed by RNA-seq and in silico species separation. This approach uncovers a wide programme of neuron-induced astrocytic gene expression, involving Notch signalling, which drives and maintains astrocytic maturity and neurotransmitter uptake function, is conserved in human development, and is disrupted by neurodegeneration. Separately, hundreds of astrocytic genes are acutely regulated by synaptic activity via mechanisms involving cAMP/PKA-dependent CREB activation. This includes the coordinated activity-dependent upregulation of major astrocytic components of the astrocyte–neuron lactate shuttle, leading to a CREB-dependent increase in astrocytic glucose metabolism and elevated lactate export. Moreover, the groups of astrocytic genes induced by neurons or neuronal activity both show age-dependent decline in humans. Thus, neurons and neuronal activity regulate the astrocytic transcriptome with the potential to shape astrocyte–neuron metabolic cooperation.
Journal of Biological Chemistry | 2016
Jamie R. K. Marland; Philip Hasel; Katherine Bonnycastle; Michael A. Cousin
Presynaptic calcium influx triggers synaptic vesicle (SV) exocytosis and modulates subsequent SV endocytosis. A number of calcium clearance mechanisms are present in central nerve terminals that regulate intracellular free calcium levels both during and after stimulation. During action potential stimulation, mitochondria rapidly accumulate presynaptic calcium via the mitochondrial calcium uniporter (MCU). The role of mitochondrial calcium uptake in modulating SV recycling has been debated extensively, but a definitive conclusion has not been achieved. To directly address this question, we manipulated the expression of the MCU channel subunit in primary cultures of neurons expressing a genetically encoded reporter of SV turnover. Knockdown of MCU resulted in ablation of activity-dependent mitochondrial calcium uptake but had no effect on the rate or extent of SV exocytosis. In contrast, the rate of SV endocytosis was increased in the absence of mitochondrial calcium uptake and slowed when MCU was overexpressed. MCU knockdown did not perturb activity-dependent increases in presynaptic free calcium, suggesting that SV endocytosis may be controlled by calcium accumulation and efflux from mitochondria in their immediate vicinity.
Biochimica et Biophysica Acta | 2015
Philip Hasel; Sean McKay; Jing Qiu; Giles E. Hardingham
Neurodegenerative and neurological disorders are often characterised by pathological changes to dendrites, in advance of neuronal death. Oxidative stress, energy deficits and excitotoxicity are implicated in many such disorders, suggesting a potential vulnerability of dendrites to these situations. Here we have studied dendritic vs. somatic responses of primary cortical neurons to these types of challenges in real-time. Using a genetically encoded indicator of intracellular redox potential (Grx1-roGFP2) we found that, compared to the soma, dendritic regions exhibited more dramatic fluctuations in redox potential in response to sub-lethal ROS exposure, and existed in a basally more oxidised state. We also studied the responses of dendritic and somatic regions to excitotoxic NMDA receptor activity. Both dendritic and somatic regions experienced similar increases in cytoplasmic Ca2+. Interestingly, while mitochondrial Ca2+ uptake and initial mitochondrial depolarisation were similar in both regions, secondary delayed mitochondrial depolarisation was far weaker in dendrites, potentially as a result of less NADH depletion. Despite this, ATP levels were found to fall faster in dendritic regions. Finally we studied the responses of dendritic and somatic regions to energetically demanding action potential burst activity. Burst activity triggered PDH dephosphorylation, increases in oxygen consumption and cellular NADH:NAD ratio. Compared to somatic regions, dendritic regions exhibited a smaller degree of mitochondrial Ca2+ uptake, lower fold-induction of NADH and larger reduction in ATP levels. Collectively, these data reveal that dendritic regions of primary neurons are vulnerable to greater energetic and redox fluctuations than the cell body, which may contribute to disease-associated dendritic damage. This article is part of a Special Issue entitled: 13th European Symposium on Calcium.
PLOS ONE | 2016
Nóra M. Márkus; Philip Hasel; Jing Qiu; Karen Bell; Samuel Heron; Peter C. Kind; Owen Dando; T. Ian Simpson; Giles E. Hardingham
Uptake of Ca2+ into the mitochondrial matrix controls cellular metabolism and survival-death pathways. Several genes are implicated in controlling mitochondrial Ca2+ uptake (mitochondrial calcium regulatory genes, MCRGs), however, less is known about the factors which influence their expression level. Here we have compared MCRG mRNA expression, in neural cells of differing type (cortical neurons vs. astrocytes), differing neuronal subtype (CA3 vs. CA1 hippocampus) and in response to Ca2+ influx, using a combination of qPCR and RNA-seq analysis. Of note, we find that the Mcu-regulating Micu gene family profile differs substantially between neurons and astrocytes, while expression of Mcu itself is markedly different between CA3 and CA1 regions in the adult hippocampus. Moreover, dynamic control of MCRG mRNA expression in response to membrane depolarization-induced Ca2+ influx is also apparent, resulting in repression of Letm1, as well as Mcu. Thus, the mRNA expression profile of MCRGs is not fixed, which may cause differences in the coupling between cytoplasmic and mitochondrial Ca2+, as well as diversity of mitochondrial Ca2+ uptake mechanisms.
The Lancet | 2017
Zoeb Jiwaji; Philip Hasel; Siddharthan Chandran; Giles E. Hardingham
Abstract Background The CNS has high energy requirements and CNS metabolism is often disrupted in disease. Astrocytes, the predominant CNS glucose utilisers, convert glucose to lactate to fuel neuronal metabolism. However, the extent to which this pathway is regulated by neuronal activity is poorly understood. We hypothesised that neuronal activity increases astrocytic metabolism, and have investigated the signalling underlying neuron–astrocyte metabolic crosstalk in mouse and human systems. Methods Primary mouse or human stem-cell derived astrocytes, expressing fluorescence-resonance energy transfer (FRET) biosensors for glucose or lactate, were co-cultured in vitro with primary cortical neurons. Neuronal activity was altered with 24 h of bicuculline (high activity) or tetrodotoxin (low activity). Glucose and lactate flux were determined by the rate of change of FRET ratio after inhibition of glucose uptake or lactate export. Transcriptomic analysis was done by RNA sequencing. Findings Neuronal activity increased glucose metabolism in mouse astrocytes (rate of change in FRET ratio: bicuculline mean 1·58 per s [SD 0·17] vs tetrodotoxin 0·620 [0·20], p vs 0·775 [0·19], p vs 0·281 [0·21], p=0·028). Metabolic changes persisted after transfer from high to low activity conditions. Transcriptome analysis found activity-dependent upregulation of major components of the astrocyte–neuron lactate shuttle, with enrichment for the cAMP response element (CREB) promoter motif. CREB inhibition reversed activity-induced effects, and constitutively-active CREB was sufficient to increase astrocyte metabolism in low-activity conditions. Interpretation Our study found that neuronal activity, in mouse and human astrocytes, drove expression of metabolic genes and led to long-lasting enhancement of pathways for astrocyte–neuron metabolic support. These activity-dependent changes occured via activation of the CREB signalling pathway. These findings could have consequences for CNS metabolism when neuronal activity is reduced after neurodegeneration or iatrogenically during prolonged anaesthesia or sedation. Funding Wellcome Trust.
Nature Protocols | 2018
Jing Qiu; Owen Dando; Paul Baxter; Philip Hasel; Samuel Heron; T. Ian Simpson; Giles E. Hardingham
Transcriptomic changes induced in one cell type by another mediate many biological processes in the brain and elsewhere; however, achieving artifact-free physical separation of cell types to study them is challenging and generally allows for analysis of only a single cell type. We describe an approach using a co-culture of distinct cell types from different species that enables physical cell sorting to be replaced by in silico RNA sequencing (RNA-seq) read sorting, which is possible because of evolutionary divergence of messenger RNA (mRNA) sequences. As an exemplary experiment, we describe the co-culture of purified neurons, astrocytes, and microglia from different species (12–14 d). We describe how to use our Python tool, Sargasso, to separate the reads from conventional RNA-seq according to species and to eliminate any artifacts borne of imperfect genome annotation (10 h). We show how this procedure, which requires no special skills beyond those that might normally be expected of wet lab and bioinformatics researchers, enables the simultaneous transcriptomic profiling of different cell types, revealing the distinct influence of microglia on astrocytic and neuronal transcriptomes under inflammatory conditions.This protocol describes the co-culture of cells from multiple species and, after RNA-seq, the separation of reads by species via the Sargasso bioinformatics pipeline to elucidate the effects of one cell type on the transcriptome of the others.
Nature Communications | 2018
Philip Hasel; Owen Dando; Zoeb Jiwaji; Paul Baxter; Alison C. Todd; Samuel Heron; Nóra M. Márkus; Jamie McQueen; David W. Hampton; Megan Torvell; Sachin S. Tiwari; Sean McKay; Abel Eraso-Pichot; Antonio Zorzano; Roser Masgrau; Elena Galea; Siddharthan Chandran; David J. A. Wyllie; T. Ian Simpson; Giles E. Hardingham
This corrects the article DOI: 10.1038/ncomms15132.
Cell Reports | 2018
Sean McKay; Tomás J. Ryan; Jamie McQueen; Tim Indersmitten; Katie Marwick; Philip Hasel; Maksym V. Kopanitsa; Paul Baxter; Marc-André Martel; Peter C. Kind; David J. A. Wyllie; Thomas J. O’Dell; Seth G. N. Grant; Giles E. Hardingham; Noboru H. Komiyama
Summary The GluN2 subtype (2A versus 2B) determines biophysical properties and signaling of forebrain NMDA receptors (NMDARs). During development, GluN2A becomes incorporated into previously GluN2B-dominated NMDARs. This “switch” is proposed to be driven by distinct features of GluN2 cytoplasmic C-terminal domains (CTDs), including a unique CaMKII interaction site in GluN2B that drives removal from the synapse. However, these models remain untested in the context of endogenous NMDARs. We show that, although mutating the endogenous GluN2B CaMKII site has secondary effects on GluN2B CTD phosphorylation, the developmental changes in NMDAR composition occur normally and measures of plasticity and synaptogenesis are unaffected. Moreover, the switch proceeds normally in mice that have the GluN2A CTD replaced by that of GluN2B and commences without an observable decline in GluN2B levels but is impaired by GluN2A haploinsufficiency. Thus, GluN2A expression levels, and not GluN2 subtype-specific CTD-driven events, are the overriding factor in the developmental switch in NMDAR composition.